logologo
QuantliQuantli

Pyxis Oncology Inc

PYXS

NASDAQ

Biotechnology

$3.01

USD

0.00 (0.00%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $190.70M

Volume 701.1K

Price Target

$7.00$7.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $7.00 and a min estimate of $7.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$7.00

Unchanged vs prior

Implied Upside

+132.6%

Unchanged vs prior

Analyst Covering

1

-2 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

25%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Jeffrey La Rosa

Leerink Partners

Buy

Maintained

1 month ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

HUMA

Humacyte Inc

$0.6000

+10.0%

ABOS

Acumen Pharmaceuticals Inc

$2.67

+4.7%

KROS

Keros Therapeutics Inc

$10.10

-5.3%

PEPG

PepGen Inc

$2.99

+0.3%

KRRO

Korro Bio Inc

$13.28

-0.1%

CHRS

Coherus Oncology Inc

$1.20

+5.3%

VYGR

Voyager Therapeutics Inc

$3.27

+1.6%

CRBP

Corbus Pharmaceuticals Holdings Inc

$10.09

+0.1%